Does Intravenous Immunoglobulin Administration Affect the Clearance of Monoclonal Antibodies in Transplant Recipients?

Transplantation. 2024 May 1;108(5):e69-e71. doi: 10.1097/TP.0000000000004921. Epub 2024 Jan 26.

Authors

Victoria Reams¹, Amir M Emtiazjoo², Cynthia Gries², Mindaugus Rackauskas³, Biplab K Saha²

Affiliations

¹ Division of Pharmacy, University of Florida, Gainesville, FL.
² Lung Transplant and ECMO Program, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL.
³ Department of Thoracic Surgery, University of Florida, Gainesville, FL.

PMID: 38277265
DOI: 10.1097/TP.0000000000004921

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal* / administration & dosage
Antibodies, Monoclonal* / adverse effects
Graft Rejection / immunology
Graft Rejection / prevention & control
Humans
Immunoglobulins, Intravenous* / administration & dosage
Immunoglobulins, Intravenous* / therapeutic use
Metabolic Clearance Rate
Transplant Recipients

Substances

Immunoglobulins, Intravenous
Antibodies, Monoclonal